Avandia (rosiglitazone), a medication for people with type 2 diabetes, has been the subject of studies evaluating its safety and the results aren’t what Glaxo (the manufacturer) had hoped for. According to researchers in Toronto, Canada, elderly people who take Avandia may have an increased risk of heart failure and death.
The researchers didn’t, however, find the same results that American researchers found two years earlier, which suggested that Avandia also increased the risk of heart attacks. The Canadian researchers found no difference between patients who took Avandia and another type of medication, Actos (pioglitazone), and the rate of heart attacks …read more

Over 20% of all diabetics have heart disease. That is why it is so scary when new research and studies come out that prove diabetic medication to harm your heart. And here we go again… Two Wake Forest University School of Medicine faculty members sifted through three trials to come to the conclusion that certain diabetic medications could cause increased heart failure- ACCORD, ADVANCE, and the Veterans Affairs Diabetes study.
“We strongly recommend restrictions in the use of thiazolidinediones (the class of drugs) and question the rationale for leaving rosiglitazone on the market,” write Sonal Singh, M.D., M.P.H., assistant professor of …read more

I posted this as well over at Diabetes Notes, but I think it is big enough news that you will excuse the duplication.
Ok, it is official… Avandia will stay on the market.  The FDA voted an overwhelming yes to keeping the drug on the shelves.  They stated that they are recommending that there be warning labels for the elder population and high risk cardiac patients. 
And as you can guess, this is getting a bag of mixed emotions.  Will this stop the 1000’s of lawsuits that are currently existing due to Avandia’s heart implications?  I think not.  But it will give …read more